Patient Care and Research

ASTRO Guideline on Stereotactic Body Radiation Therapy (SBRT) for Early Stage Non-small Cell Lung Cancer (NSCLC)

Published: September 2017 (Web posted June 2017)

Read Executive Summary
Read Full-Text Guideline

This guideline evaluates the following four key questions regarding SBRT inch allenging clinical scenarios in early-stage NSCLC: 1) application of SBRT to operable patients; 2) appropriate use of SBRT in tumors that are centrally located, large, multifocal or unbiopsied, and 3) in individual tailoring of SBRT in “high-risk” clinical scenarios; and 4) SBRT as salvage therapy after recurrence.

Endorsed by:

  • American Society of Clinical Oncology
  • European Society for Radiotherapy and Oncology
  • The Royal Australian and New Zealand College of Radiologists

Key Points:

  • SBRT as alternative to surgery
  • SBRT techniques for medically inoperable patients


Comparison of the Effectiveness of Radiofrequency Ablation with SBRT in Inoperable Stage I NSCLC (CME)
ASTRO’s SBRT Model Policy 
Patient Brochure


We have recently updated our privacy policy and terms of use.
By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use.
We use cookies to provide, secure and improve our services to you. To learn more, click here.